Dr. Ilham Saleh Abuljadayel

Dr. Ilham Saleh Abuljadayel
, Head of Stem Cell Research and Therapy at TriStem Corporation, founder of the Retrodifferentiation Technology and co-founder of TriStem Corporation ltd.

"Dr. Ilham Saleh Abuljadayel is the sole inventor of the TriStem Technology. She discovered the process of retrodifferentiation in the early nineties and also developed ways of committing the retrodifferentiated cells into a variety of cells/tissue types, including haematopoietic, neuronal, mesenchymal, cardiomyogenic, endothelial and exocrine cell lineages etc. Based on her research, Dr. Abuljadayel co-founded the TriStem Group. She received her Bachelor's degree in Cell Biology (1985) and her Ph.D in Immunology (1990) from King's College , University of London. Dr. Abuljadayel has been working as a molecular and cellular biologist since 1982 and has published various articles in peer reviewed journals. During the period 1990 to 1997 Dr Abuljadayel worked as a consultant immunologist at the King Fahd Armed Forces Hospital in Jeddah. Dr. Abuljadayel carried out her research at King's College London, the Royal London Hospital and University of Cambridge."

A video of a case has been treated & uploaded by the Dr.Ilham, 

Published on Oct 9, 2012

"Infusion of Autologous Retrodifferentiated Neuronal Stem Cells into a patient suffering from Parkinson Disease. Patients leukocytes direct reprogramming into neuronal stem cells and therapy via retrodifferentiation"